David Kliff of Diabetic Investor was the first to report last week that Animas, the Johnson and Johnson unit that makes the OneTouch Ping blood glucose monitor, is recalling the Ping. The brand-new Ping received FDA clearance this past summer on July 1. According to reports, there is a small problem with the Ping that has nothing to do with the Animas 2020 insulin pump it works in concert with. The bolus calculator on the Ping does not work properly when it isn’t synched with the pump. When the two are synched, it works fine. Animas says the problem has been corrected and they are sending new units to customers to replace the defective ones.
Kliff said in his newsletter that he doesn’t see it as “an overly serious issue.” he writes, “Based on everything Diabetic Investor has learned, the issue is software-related and Animas is being proactive here [in] not letting a minor issue turn into a major one.”
For more information, call Animas at (877) 937-7867.